"Antipyrine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
Descriptor ID |
D000983
|
MeSH Number(s) |
D03.383.129.539.850.088
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antipyrine".
Below are MeSH descriptors whose meaning is more specific than "Antipyrine".
This graph shows the total number of publications written about "Antipyrine" by people in this website by year, and whether "Antipyrine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antipyrine" by people in Profiles.
-
The lncRNA H19 alleviates muscular dystrophy by stabilizing dystrophin. Nat Cell Biol. 2020 11; 22(11):1332-1345.
-
Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery. Cochrane Database Syst Rev. 2018 07 09; 7:CD011492.
-
Cerebrovascular reactivity to CO(2) and hypotension after mild cortical impact injury. Am J Physiol. 1999 10; 277(4):H1457-66.
-
Hepatic drug clearance in patients with mild cystic fibrosis. Clin Pharmacol Ther. 1996 May; 59(5):529-40.
-
Radial columns in autoradiographs generated from tracer methods for measuring cerebral cortical blood flow. Am J Physiol. 1995 Aug; 269(2 Pt 2):H583-9.
-
Investigation of copper-PTSM as a PET tracer for tumor blood flow. Int J Rad Appl Instrum B. 1991; 18(7):807-11.
-
Enhanced hepatic drug clearance in patients with cystic fibrosis. J Pediatr. 1990 Dec; 117(6):972-9.
-
Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans. J Pharmacol Exp Ther. 1988 Mar; 244(3):994-9.
-
Diltiazem treatment impairs hepatic drug oxidation: studies of antipyrine. Clin Pharmacol Ther. 1986 Aug; 40(2):140-3.